Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Employment agrmnt
Appointed director
CC transcript
Director departure

Accelerate Diagnostics, Inc (AXDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/08/2019 GN Factors of Influence in 2019, Key Indicators and Opportunity within New Relic, Clean Harbors, Sage Therapeutics, Accelerate Diagnostics, Fortinet, and Colfax — New Research Emphasizes Economic Growth
11/09/2018 GN Analysis: Positioning to Benefit within CSS Industries, Accelerate Diagnostics, Oasis Petroleum, Model N, Carbonite, and Masonite International — Research Highlights Growth, Revenue, and Consolidated Results
10/15/2018 GN Factors of Influence in 2018, Key Indicators and Opportunity within Meritor, Fred's, Arena Pharmaceuticals, AMERISAFE, Accelerate Diagnostics, and NextEra Energy — New Research Emphasizes Economic Growth
07/19/2018 GN Accelerate Diagnostics to Review Second Quarter 2018 Results on August 6th
06/05/2018 GN Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
05/09/2018 GN Accelerate Diagnostics reports Q1 2018 financial results
05/04/2018 GN Report: Developing Opportunities within US Ecology, Universal Health Realty Income Trust, Accelerate Diagnostics, Chesapeake Lodging Trust, Super Micro Computer, and Choice Hotels International — Future Expectations, Projections Moving into 2018
04/30/2018 GN Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th
04/21/2018 GN Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
03/23/2018 GN Accelerate Diagnostics, Inc. Announces Pricing of $150 Million Convertible Notes Offering
03/22/2018 GN Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering
03/02/2018 GN Report: Exploring Fundamental Drivers Behind Accelerate Diagnostics, FTI Consulting, Spark Therapeutics, Achaogen, Oxford Industries, and Kronos Worldwide — New Horizons, Emerging Trends, and Upcoming Developments
02/15/2018 GN Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
02/08/2018 GN Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
01/08/2018 GN New Research Coverage Highlights ConnectOne, Rockwell Medical, Accelerate Diagnostics, Eleven Biotherapeutics, Renasant, and Natera — Consolidated Revenues, Company Growth, and Expectations for 2018
01/04/2018 GN Accelerate Diagnostics to Present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco
11/27/2017 GN Accelerate Diagnostics Joins Sepsis Alliance in Global #GivingTuesday Movement to Raise Awareness of Sepsis as Medical Emergency
11/16/2017 GN Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors
11/15/2017 GN Accelerate Diagnostics to Present at the 29th Annual Piper Jaffray Healthcare Conference in New York City
11/02/2017 GN Accelerate Diagnostics reports Q3 2017 financial results
10/16/2017 GN Accelerate Diagnostics Schedules Call to Review Third Quarter 2017 Results for November 2nd
09/13/2017 GN Plaintiffs Dismiss Class Action Appeal Against Accelerate Diagnostics
07/18/2017 GN Accelerate Diagnostics Schedules Call to Review Second Quarter 2017 Results for August 3rd
06/07/2017 GN Accelerate Diagnostics to Present at the 37th Annual Growth Stock Conference hosted by William Blair & Company
05/30/2017 GN Accelerate Diagnostics announces sizeable release of data at ASM Microbe 2017
05/09/2017 GN Accelerate Diagnostics Announces Pricing of Upsized Public Offering of Common Stock
04/18/2017 GN Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd
03/15/2017 GN Accelerate Diagnostics Names Tom Brown to Board of Directors
02/23/2017 GN Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit
02/23/2017 GN Accelerate Diagnostics to Report Preliminary Fourth Quarter and Full Year 2016 Results on February 27th

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy